Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.08B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.29B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$752M |
| 4 |
Microsoft
MSFT
|
+$699M |
| 5 |
NVIDIA
NVDA
|
+$578M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$4.9B |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$986M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$951M |
| 4 |
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
|
+$794M |
| 5 |
Schwab Fundamental International Small Company Index ETF
FNDC
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.55% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 9.33% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Viemed Healthcare
VMD
$353M
| $728K | ﹤0.01% |
105,386
+5,878
| +6% | +$39.9K |
|
3002
Freedom Holding
FRHC
$9.61B
| $727K | ﹤0.01% |
+4,981
| New | +$735K |
|
3003
Blue Ridge Bankshares
BRBS
$334M
| $725K | ﹤0.01% |
202,074
+161,477
| +398% | +$544K |
|
3004
Coherus Oncology
CHRS
$187M
| $718K | ﹤0.01% |
981,372
+30,696
| +3% | +$26.5K |
|
3005
Immersion
IMMR
$248M
| $717K | ﹤0.01% |
90,969
+3,505
| +4% | +$26.1K |
|
3006
Vanguard Health Care ETF
VHT
$19B
| $716K | ﹤0.01% |
2,883
-244
| -8% | -$60.3K |
|
3007
Oportun Financial
OPRT
$350M
| $716K | ﹤0.01% |
99,939
+83,939
| +525% | +$504K |
|
3008
WPP
WPP
$5.83B
| $713K | ﹤0.01% |
20,376
+11,368
| +126% | +$426K |
|
3009
Lifecore Biomedical
LFCR
$183M
| $712K | ﹤0.01% |
87,690
+8,195
| +10% | +$55.2K |
|
3010
Compass Therapeutics
CMPX
$396M
| $711K | ﹤0.01% |
273,472
-24,408
| -8% | -$50.3K |
|
|
EEX
3011
DELISTED
Emerald Holding
EEX
| $707K | ﹤0.01% |
145,842
+309
| +0.2% | +$1.35K |
|
|
GPMT
3012
Granite Point Mortgage Trust
GPMT
$60.2M
| $707K | ﹤0.01% |
286,080
-116,712
| -29% | -$262K |
|
3013
Orange County Bancorp
OBT
$520M
| $705K | ﹤0.01% |
27,269
-575
| -2% | -$14K |
|
3014
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.9B
| $701K | ﹤0.01% |
7,353
+2,400
| +48% | +$206K |
|
3015
STRATTEC Security
STRT
$349M
| $699K | ﹤0.01% |
+11,242
| New | +$519K |
|
3016
ReposiTrak
TRAK
$156M
| $699K | ﹤0.01% |
35,570
+1,527
| +4% | +$32K |
|
|
KWY
3017
Kingsway Corp
KWY
$282M
| $699K | ﹤0.01% |
51,592
+15,508
| +43% | +$165K |
|
3018
Timberland Bancorp
TSBK
$355M
| $698K | ﹤0.01% |
22,380
+1
| +0% | +$30 |
|
|
RZLV
3019
Rezolve AI
RZLV
$1.11B
| $698K | ﹤0.01% |
+226,983
| New | +$447K |
|
3020
Palladyne AI
PDYN
$312M
| $697K | ﹤0.01% |
80,443
+64,328
| +399% | +$456K |
|
3021
OptimizeRx
OPRX
$130M
| $695K | ﹤0.01% |
51,512
-2,716
| -5% | -$29.7K |
|
|
SGMO
3022
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $694K | ﹤0.01% |
1,281,799
+183,965
| +17% | +$109K |
|
3023
Paysign
PAYS
$713M
| $694K | ﹤0.01% |
96,320
+4,705
| +5% | +$16.9K |
|
3024
Asure Software
ASUR
$243M
| $692K | ﹤0.01% |
70,874
+3,407
| +5% | +$32.8K |
|
3025
Primis Financial Corp
FRST
$405M
| $691K | ﹤0.01% |
63,665
-322
| -0.5% | -$2.96K |
|
Similar funds
Charles Schwab's Q2 2025 Portfolio in Review
As of Q2 2025, Charles Schwab held 3,631 positions worth $578B, up 8.5% from $533B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab's Q2 2025 filing shows 158 new, 2,252 increased, 1,020 reduced and 137 closed positions. Its largest new stake was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B. The largest sale was Vanguard Mortgage-Backed Securities ETF, an estimated $4.9B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2025 buy was Schwab Mortgage-Backed Securities ETF: 202,020,489 shares worth $5.15B.
- Charles Schwab added most to Schwab Municipal Bond ETF in Q2 2025, an estimated $1.29B increase.
- Charles Schwab's biggest Q2 2025 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $4.9B.
- Charles Schwab fully exited Invesco FTSE RAFI US 1000 ETF in Q2 2025, selling an estimated $986M.
- Charles Schwab's ten largest holdings make up 23% of its $578B portfolio in Q2 2025.
- Charles Schwab opened 158 new positions and closed 137 in Q2 2025.
- Charles Schwab's portfolio value rose 8.5% quarter-over-quarter to $578B.
Based on Charles Schwab's 13F filing for Q2 2025, filed 12 Aug 2025.